Zydus Wellness Q4FY25: Revenue rises 17.1% to Rs 910.6 crore, net profit jumps 14.3% YoY to Rs 171.9 crore
By News Desk Published on May 19, 2025, 12:54 IST
Zydus Wellness Limited announced its financial results for the quarter and year ended March 31, 2025. For Q4FY25, the company reported a revenue of ₹910.6 crore, up 17.1% year-on-year from ₹778 crore. Net profit for the quarter rose 14.3% YoY to ₹171.9 crore from ₹150.3 crore in the same quarter last year.
For the full financial year FY25, Zydus Wellness posted a revenue of ₹2,691.2 crore, compared to ₹2,315.2 crore in FY24. Net profit for the year increased to ₹346.9 crore, from ₹266.9 crore in the previous year.
In its board meeting held on May 19, 2025, the company also approved the following: A final dividend of ₹6 per share (60% on face value of ₹10), with a record date set for July 11, 2025. Payment will be made on or after August 4, 2025, subject to shareholder approval at the AGM.
The 31st Annual General Meeting will be held on July 30, 2025, via video conferencing.
A 1:5 stock split has been proposed, where each ₹10 share will be split into five ₹2 shares, aimed at enhancing retail participation.
Appointment of Hitesh Buch & Associates as secretarial auditors for a five-year term (FY26–FY30).
Reappointment of Mukesh M. Shah & Co. as statutory auditors for a second five-year term (FY26–FY30).
The share split is expected to be completed within two months from shareholder approval.
News desk at BusinessUpturn.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
3 hours ago
- Business Upturn
Asian markets trade mixed as global cues weigh; Japan, Hong Kong slip while China, South Korea gain
By News Desk Published on June 12, 2025, 08:40 IST Asian equity markets opened on a mixed note on June 12, with regional benchmarks reacting cautiously to global trade concerns, geopolitical tensions, and U.S. policy signals. While China and South Korea managed modest gains, Japan and Hong Kong indices declined amid profit booking and risk aversion. In Japan, the Nikkei 225 fell 0.71% to 38,149.44, leading regional losses as investors trimmed positions in heavyweight and tech stocks. The broader TOPIX Index also shed 0.40%, while the TOPIX 100 Index declined 0.48%, reflecting widespread weakness across sectors. Sentiment was further dampened ahead of upcoming guidance from the Bank of Japan. Hong Kong markets also opened in the red. The Hang Seng Index slipped 0.36% to 24,279.24, while the Hang Seng TECH Index dropped 0.92%, hit by a sell-off in growth stocks. The Hang Seng China Enterprises Index and Hang Seng China 50 Index were down 0.33% and 0.32%, respectively, as investors exercised caution amid global volatility. On the other hand, Mainland China indices saw marginal gains. The SSE Composite Index rose 0.04% to 3,403.69, while the CSI 1000 Index advanced 0.22%, outperforming broader benchmarks. The Shenzhen Component Index and SZSE Composite Index also registered slight upticks, indicating selective buying in small-cap and tech counters. South Korea's KOSPI Composite Index led regional gainers, rising 0.54% to 2,922.84. The KOSPI 200 and KOSPI LargeCap Index were up 0.36% and 0.50%, respectively, supported by foreign inflows and optimism in select blue-chip names. Overall, Asian markets reflected a cautious risk tone, with investors monitoring U.S. tariff rhetoric, Middle East developments, and regional policy cues to navigate short-term volatility. Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should consult certified financial advisors before making any investment decisions. News desk at
Yahoo
7 hours ago
- Yahoo
Oasis Intends to Vote Against Kyocera's Top Management at the Upcoming AGM
*Kyocera has been facing chronic underperformance, with its stock price remaining depressed over the long-term and profitability continuing to deteriorate sharply *Although Kyocera has announced certain management reform initiatives, they fall far short of the necessary fundamental changes needed to transform the Company *On May 14, Oasis released a "Seven-Point Plan" calling for more substantive reforms at Kyocera, including the acceleration of non-core business divestitures and improvements to the Company's inefficient capital structure *However, Kyocera has so far failed to address the "Seven Point Plan" and has demonstrated little commitment to genuine transformation *In its latest results, Kyocera achieved an ROE of just 0.8% *Oasis will vote against the reappointment of Chairman Yamaguchi and President Tanimoto at the upcoming AGM, holding them accountable for the underperformance and poor capital allocation *Both ISS and Glass Lewis have recommended to vote against the reappointment of Kyocera Chairman Yamaguchi, and ISS additionally recommends voting against President Tanimoto More information available at HONG KONG, June 11, 2025--(BUSINESS WIRE)--Oasis Management Company Ltd. ("Oasis") is manager to funds that beneficially own shares in Kyocera Corporation (6971 JP) ("Kyocera" or the "Company"). Oasis has adopted the Japan FSA's "Principles of Responsible Institutional Investors" (a.k.a. the Japan Stewardship Code) and in line with those principles, Oasis monitors and engages with its investee companies. At its May 14, 2025 earnings call, Kyocera reported on the progress of its management reforms. The Company appeared to acknowledge its past mistakes and expressed an intention to take the first step toward change. Specifically, Kyocera recognized the inefficiencies caused by the dispersal of management resources due to diversification and announced its policy to restructure its business portfolio in order to focus on its core strengths. However, like many shareholders and market participants, Oasis remains highly skeptical of Kyocera's commitment and ability to execute meaningful change especially in light of its modest plans and continued commitment to manufacturing solar panels and telecommunication devices. Moreover, underperformance against its management targets has become the norm. Since the fiscal year ended March 2020, Kyocera has exceeded its operating profit targets only once. This track record raises serious concerns about the current management team's ability to formulate and execute plans, casting significant doubt on whether they can even implement the current, modest reform plan. The latest earnings briefing further highlighted weak progress. Although Kyocera announced plans to exit JPY200 billion worth of non-core businesses, only JPY7.3 billion has been announced so far. This year's forecast includes just a JPY10 billion revenue reduction from exits. Kyocera's capital policy also remains insufficient. Although the Company has announced "Future Reduction Plan" to lower cross-shareholdings to below 20% of net assets, it has yet to provide a clear timeline for achieving this goal. Shareholders' dissatisfaction is growing. Approval for the Company's president at the AGM has dropped from 96% in 2015 to just 65% in 2023. ISS and Glass Lewis have once again recommended voting against the reappointment of Kyocera's Chairman, Mr. Yamaguchi. ISS has also recommended voting against President, Mr. Tanimoto, citing continued underperformance in ROE and capital misallocation. Oasis also believes that the top management is responsible for Kyocera's weak performance and therefore intends to vote against the reappointment of both individuals. Amid growing pressure from shareholders, Kyocera announced plans to reduce the cap on board directors from 20 to 12. At the same time, the Company also plans to increase the number of internal directors -- a move that runs against the broader efforts by many Japanese companies to strengthen board independence thereby decreasing the percentage of independent directors. In order for Kyocera to achieve genuine transformation and resolve its excessive diversification and inefficient capital structure, Oasis urges the full implementation of the following Seven-Point Plan: Divest non-core businesses amounting to over JPY660 billion of revenue. Exit the Organic Packages to prevent further losses. Restructure its KAVX subsidiary to achieve higher margins in line with peers. Stop losses by halting investment into GaN and millimeter-wave technologies which have little potential to produce material returns. Focus on its core business such as ceramics to capture untapped opportunities. Commit to aggressive M&A to reinforce core businesses. Announce a buyback program of JPY1 trillion over the next four years, amounting to approximately 37% of the Company. By implementing this plan, we believe that the stock could see an upside of over +100% from current levels. Seth Fischer, Founder & Chief Investment Officer of Oasis, said: "Kyocera's excessive diversification has long prevented it from realizing its full potential. The Company continues to support underperforming businesses while failing to prioritize investment and growth opportunities within its best businesses such as ceramics packaging, and the automotive and semiconductor sectors. With cross-shareholdings still accounting for 53% of its net assets and an ROE of just 0.8%, the time for meaningful change is now. Management needs to address the twin problems of over-diversification and over-capitalization of its balance sheet by exiting underperforming businesses, leaning into its best growth opportunities, and taking a much more ambitious stance on unwinding cross-shareholdings to improve returns on capital. Kyocera needs brave, large steps forward to achieve these goals. The current half measures are not enough." Full details can be viewed at All stakeholders are encouraged to contact Oasis at info@ *** Oasis Management Company Ltd. manages private investment funds focused on opportunities in a wide array of asset classes across countries and sectors. Oasis was founded in 2002 by Seth H. Fischer, who leads the firm as its Chief Investment Officer. More information about Oasis is available at Oasis has adopted the Japan FSA's "Principles for Responsible Institutional Investors" (a.k.a. the Japan Stewardship Code) and, in line with those principles, Oasis monitors and engages with our investee companies. The information and opinions contained in this press release (referred to as the "Document") are provided by Oasis Management Company ("Oasis") for informational or reference purposes only. The Document is not intended to solicit or seek shareholders to, jointly with Oasis, acquire or transfer, or exercise any voting rights or other shareholder's rights with respect to any shares or other securities of a specific company which are subject to the disclosure requirements under the large shareholding disclosure rules under the Financial Instrument and Exchange Act. Shareholders that have an agreement to jointly exercise their voting rights are regarded as Joint Holders under the Japanese large shareholding disclosure rules and they must file notification of their aggregate shareholding with the relevant Japanese authority for public disclosure under the Financial Instruments and Exchange Act. Except in the event that Oasis expressly enters into the agreement as a joint holder requiring such disclosure, Oasis does not intend to take any action triggering reporting obligations as a Joint Holder. The Document exclusively represents the opinions, interpretations, and estimates of Oasis. View source version on Contacts Media Contact For all inquiries, please contact:Taylor Hallmedia@
Yahoo
8 hours ago
- Yahoo
Voting Cards Reveal that Over 50% of Shareholders Excluding the Founding Family and Related Parties Voted For Oasis's EGM Proposals and Against Mr. Akihiro Kobayashi's Renomination at the AGM
(Securities Code: 4967 JT) *Oasis's proposals at the EGM had over majority approval, when calculated on the basis of excluding the shares owned by the founding family and its related parties (Majority of Minority, "MoM") *The Special Resolution (Agenda 1) at the AGM, which called for amendments to Kobayashi Pharma's Articles of Incorporation, received supermajority approval, which is more than two-thirds of affirmative votes out of all voting rights exercised at AGM ("Supermajority of Minority") *Additionally, over majority of voting rights at the AGM went against Mr. Akihiro Kobayashi's reappointment when calculated on MoM basis More information available at HONG KONG, June 11, 2025--(BUSINESS WIRE)--Oasis Management Company Ltd. ("Oasis") is the manager to funds that beneficially own over 10.1% of Japanese pharmaceuticals and food products manufacturer Kobayashi Pharmaceutical Co., Ltd. (4967 JT) ("Kobayashi Pharma" or the "Company"). As Kobayashi Pharma's second largest shareholder and the largest institutional shareholder, Oasis has accelerated its efforts to rebuild the Company's governance in order to secure appropriate reparations for the victims of the Beni Koji scandal, and to ensure improved product safety going forward. As part of its efforts, Oasis called for an extraordinary general shareholders' meeting ("EGM"), held a campaign at the annual general shareholders' meeting ("AGM", and together with the EGM, the "GMs"), and initiated a shareholder derivative lawsuit against its current and former board of directors (including outside directors). We are thankful for all the support of minority shareholders at the GMs. As part of our continued efforts to improve Kobayashi Pharma's corporate governance, we requested that the Company allow us to inspect the submitted voting cards for the GMs and count the voting rights exercised by the founding family and its related parties. From this inspection, Oasis discovered that the Kobayashi family and its related parties (individuals and entities that can reasonably be presumed to have long-standing close relationships with the Kobayashi family; the Kobayashi family together with such related parties collectively, the "Founding Family Related Parties") prevented improvement of Kobayashi Pharma's corporate governance by voting against, or abstaining from voting for, the amendments to its articles of incorporation (Special Resolution (Agenda 1)). The amendments were proposed by Kobayashi Pharma itself, in order to break away from its dependence on the Kobayashi family and improve its corporate governance. Given the above, in order to reveal the general shareholders' "true will" which has not been affected by the Kobayashi family's intent, we recalculated the number of exercised voting rights, excluding those of the Founding Family Related Parties who voted against the Company's proposal for improvement of corporate governance. As a result, on MoM basis, we found that Oasis's proposals at the EGM all received over 50% of approval. We also confirmed that the proposal for amendments to Kobayashi Pharma's Articles of Incorporation received Supermajority (i.e., more than two-thirds majority) support on MoM basis, and that the majority of all exercised voting rights were against Mr. Akihiro Kobayashi's reappointment at the AGM. Please see the accompanying graphs, "Voting at EGM" and "Voting at AGM". Oasis will continue to explore all possible options to prevent the recurrence of the Beni-Koji scandal and to improve corporate governance by breaking the Company's dependence on its founding family. Additionally, Oasis strongly requests that, taking into account the Founding Family Related Parties' exercise of voting rights (i.e., opposition to amendments of articles of incorporation for the purpose of improving corporate governance), Kobayashi Pharma require Mr. Kazumasa Kobayashi and Mr. Akihiro Kobayashi to resign from their roles as Special Advisor and Director in charge of compensation, respectively. To learn more please visit We welcome all stakeholders to contact Oasis at info@ to help improve Kobayashi Pharma's corporate governance and, thus, ensure consumer safety. *** Oasis Management Company Ltd. manages private investment funds focused on opportunities in a wide array of asset classes across countries and sectors. Oasis was founded in 2002 by Seth H. Fischer, who leads the firm as its Chief Investment Officer. More information about Oasis is available at Oasis has adopted the Japan FSA's "Principles of Responsible Institutional Investors" (a/k/a the Japan Stewardship Code) and, in line with those principles, Oasis monitors and engages with our investee companies. The information and opinion contained in this press release (referred to as the "Document") is provided by Oasis Management Company ("Oasis") for informational purposes only or for reference purposes only. The Document is not intended to solicit or seek shareholders to, jointly with Oasis, acquire or transfer, or exercise any voting rights or other shareholder's rights with respect to any shares or other securities of a specific company which are subject to the disclosure requirements under the large shareholding disclosure rules under the Financial Instrument and Exchange Act ("FIEA"). Shareholders that have an agreement to jointly acquire or transfer, or exercise their voting rights or other shareholder's rights with respect to any shares or other securities of a specific company are regarded as Joint Holders under the Japanese large shareholding disclosure rules and they must file notification of their aggregate shareholding with the relevant Japanese authority for public disclosure under the Financial Instruments and Exchange Act. Except for the case where Oasis expressly enters into such agreement, Oasis does not intend to be treated as a Joint Holder and/or a Specially Related Person with other shareholders under the Japanese FIEA or to take any action triggering reporting obligations as a Joint Holder. Oasis does not have any intention to receive any power to represent other shareholders in relation to the exercise of their voting rights. The Document exclusively represents the opinions, interpretations, and estimates of Oasis. View source version on Contacts For all inquiries, please contact:Taylor Hallmedia@ Sign in to access your portfolio
